Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06717308 · ClinicalTrials.gov registry record · NA

Evaluation of a Switchable Acrylic Adhesive Drape for Safer Removal in Negative Pressure Wound Therapy Applications.

A NA study of Frequency and Type of Medical Adhesive-Related Skin Injury and NPWT Drape Seal Effectiveness Rate (or Leak Incidence Rate), sponsored by Global Biomedical Technologies.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
4
Study locations

NCT06717308 is a NA study of Frequency and Type of Medical Adhesive-Related Skin Injury and NPWT Drape Seal Effectiveness Rate (or Leak Incidence Rate) that is actively recruiting participants, run by Global Biomedical Technologies. The registered enrollment target is 300 participants. The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06717308, a NA study of Frequency and Type of Medical Adhesive-Related Skin Injury and NPWT Drape Seal Effectiveness Rate (or Leak Incidence Rate), is actively recruiting participants, sponsored by Global Biomedical Technologies.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
4
Study locations

Study Summary

Negative pressure wound therapy (NPWT) is widely used for chronic and acute wounds, severe burns, and post-operative care. Despite its benefits, the strong adhesive required to maintain an airtight seal increases the risk of medical adhesive-related skin injuries (MARSI), pain, and discomfort during removal. Global Biomedical Technologies (GBT) aims to develop an NPWT drape with "switchable adhesive" technology to enhance removal while maintaining an effective seal. This innovation is expected to benefit both single-use and serial-use NPWT applications by reducing MARSI and improving patient comfort. This project will compare the functionality and acceptability of Comfort Release® NPWT drapes with the industry-standard V.A.C. drape (KCI Technologies, Inc.) in a non-blinded randomized controlled trial. Specific Aims Aim 1: Compare Comfort Release® drapes with V.A.C. drapes in single-use NPWT applications in post-surgical patients (n=200) at Columbia University Medical Center, Weill Cornell Medical Center, and Absolute Medical Center. Milestones: Demonstrate statistically significant (α=0.05) improvement over V.A.C. drapes in: Reduction of MARSI (Medical Adhesive-Related Skin Injury scoring system) Decreased pain (Indiana Polyclinic Combined Pain Scale) Reduced need for pain/anxiety medication Equivalent or improved seal effectiveness (leak incidence rate) Clinician acceptability Aim 2: Compare Comfort Release® drapes with V.A.C. drapes in serial-use NPWT applications in chronic wound patients (n=100) at Weill Cornell Medical Center and Vital Medical Research. Patients will undergo three NPWT drape changes per week. Milestones: Demonstrate statistically significant (α=0.05) improvement over V.A.C. drapes in: Reduction of MARSI Decreased pain (Indiana Polyclinic Combined Pain Scale) Improved compliance with treatment duration Reduced need for pain/anxiety medication Equivalent or better seal effectiveness Clinician acceptability (questionnaire score \>4) Reduced

Interventions

  • DEVICE Comfort Release® NPWT drape

Study Locations (4)

Florida

  • Absolute Medical Center, LLC - Miami
  • Vital Medical Research - Sweetwater

New York

  • Columbia University Medical Center - New York
  • Weill Cornell Medical Center - New York

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-02-10
Est. Completion 2026-09-15
Phase NA

Sponsor

Global Biomedical Technologies

1 total trials

What the Registry Record Tells You About NCT06717308

The ClinicalTrials.gov registry entry for NCT06717308 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Global Biomedical Technologies, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Frequency and Type of Medical Adhesive-Related Skin Injury appearing as the primary indexed condition, and to 1 intervention - of which Comfort Release® NPWT drape is the first listed.

NCT06717308 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Florida, New York.

Frequently Asked Questions

What is clinical trial NCT06717308 about?

NCT06717308 is a clinical study titled "Evaluation of a Switchable Acrylic Adhesive Drape for Safer Removal in Negative Pressure Wound Therapy Applications.". Negative pressure wound therapy (NPWT) is widely used for chronic and acute wounds, severe burns, and post-operative care. Despite its benefits, the strong adhesive required to maintain an airtight seal increases the risk of medical adhesive-related skin injuries (MARSI), pain, and discomfort during...

What is the current status of trial NCT06717308?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-02-10. Estimated completion is 2026-09-15.

What conditions does trial NCT06717308 study?

This clinical trial studies the following conditions: Frequency and Type of Medical Adhesive-Related Skin Injury, NPWT Drape Seal Effectiveness Rate (or Leak Incidence Rate), Clinician Acceptability of New NPWT Drape, Patient Drop-out Rate From Prescribed NPWT Treatment, Pain Assessment During Medical Adhesive Drape Removal.

What interventions are being tested in trial NCT06717308?

The interventions under investigation include: Comfort Release® NPWT drape (DEVICE).

Who is sponsoring clinical trial NCT06717308?

This trial is sponsored by Global Biomedical Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06717308 being conducted?

This trial has 4 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.